UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IL-12 receptor. II. Distribution and regulation of receptor expression

The Journal of immunology (1950), 1992-05, Vol.148 (10), p.3125-3132

1992

Volltextzugriff (PDF)

Affinity requirements for induction of sequential phases of human B cell activation by membrane IgM-cross-linking ligands

The Journal of immunology (1950), 1991-03, Vol.146 (6), p.1791-1800

1991

Volltextzugriff (PDF)

The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2)

The Journal of immunology (1950), 1997-10, Vol.159 (8), p.3782-3791

1997

Volltextzugriff (PDF)

Membrane IgM-mediated signaling of human B cells. Effect of increased ligand binding site valency on the affinity and concentration requirements for inducing diverse stages of activation

The Journal of immunology (1950), 1992-06, Vol.148 (12), p.3892-3901

1992

Volltextzugriff (PDF)

HMG-CoA Reductase Inhibitors Pravastatin and Simvastatin Inhibit Human B-Lymphocyte Activation

Transplantation proceedings, 1998-06, Vol.30 (4), p.992-995

1998

Volltextzugriff (PDF)

Evidence for an upper affinity threshold for anti-IgM-induced apoptosis in a human B-cell lymphoma

Blood, 1998-11, Vol.92 (10), p.3756-3771

1998

Volltextzugriff (PDF)

Human B cell activation. Effect of T cell cytokines on the physicochemical binding requirements for achieving cell cycle progression via the membrane IgM signaling pathway

The Journal of immunology (1950), 1995-10, Vol.155 (7), p.3385-3400

1995

Volltextzugriff (PDF)

Anti-IgM-mediated B cell signaling: molecular analysis of ligand binding requisites for human B cell clonal expansion and tolerance

The Journal of experimental medicine, 1988-07, Vol.168 (1), p.247-266

1988

Volltextzugriff (PDF)

Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations

The Journal of immunology (1950), 1989-09, Vol.143 (5), p.1565-1574

1989

Volltextzugriff (PDF)

Human B cell activation. Evidence for diverse signals provided by various monoclonal anti-IgM antibodies

The Journal of experimental medicine, 1985-10, Vol.162 (4), p.1236-1255

1985

Volltextzugriff (PDF)

Biological function and distribution of human interleukin‐12 receptor β chain

European journal of immunology, 1996-02, Vol.26 (2), p.345-350

1996

Volltextzugriff (PDF)

Differential effects of cyclosporin A on diverse B cell activation phenomena triggered by crosslinking of membrane IgM

Cellular immunology, 1992-04, Vol.140 (2), p.478-494

1992

Volltextzugriff (PDF)

Cytokine Dependency of Human B Cell Cycle Progression Elicited by Ligands Which Coengage BCR and the CD21/CD19/CD81 Costimulatory Complex

Cellular immunology, 2001-02, Vol.207 (2), p.127-140

2001

Volltextzugriff (PDF)

Culture-well solid-phase 3H-RIA for the isotype-specific measurement of antibody from mouse and human antibody-secreting cells

Methods in enzymology, 1986, Vol.121, p.438-453

1986

Volltextzugriff (PDF)

Membrane IgM-Stimulated Human B Lymphocytes Succumb to Activation-Related Apoptosis at a G1→ S Transition: Influence of Ligand Affinity and Valency

Cellular immunology, 1998-09, Vol.188 (2), p.137-150

1998

Volltextzugriff (PDF)

A monovalent C mu 4-specific ligand enhances the activation of human B cells by membrane IgM cross-linking ligands

International immunology, 1995-02, Vol.7 (2), p.317-330

1995

Volltextzugriff (PDF)

Analysis of the domain specificity of various murine anti-human IgM monoclonal antibodies differing in human B lymphocyte signaling activity

Molecular immunology, 1987-08, Vol.24 (8), p.809-820

1987

Volltextzugriff (PDF)

Membrane Ig-mediated triggering of B cell tolerance and B cell clonal expansion: implications for rheumatoid factor production in rheumatoid synovitis

Springer seminars in immunopathology, 1989-01, Vol.11 (2), p.93-122

1989

Volltextzugriff (PDF)

POGLUT1 biallelic mutations cause myopathy with reduced satellite cells, α-dystroglycan hypoglycosylation and a distinctive radiological pattern

Acta neuropathologica, 2020-03, Vol.139 (3), p.565-582

2020

Volltextzugriff (PDF)

The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials

Journal of neurology, neurosurgery and psychiatry, 2016-02, Vol.87 (2), p.149-155

2016

Volltextzugriff (PDF)

Developing standardized corticosteroid treatment for Duchenne muscular dystrophy

Contemporary clinical trials, 2017-07, Vol.58, p.34-39

2017

Volltextzugriff (PDF)

Health related quality of life in young, steroid-naïve boys with Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2021-11, Vol.31 (11), p.1161-1168

2021

Volltextzugriff (PDF)

A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial

Trials, 2018-05, Vol.19 (1), p.291-291, Article 291

2018

Volltextzugriff (PDF)

Registries versus tertiary care centers: How do we measure standards of care in Duchenne muscular dystrophy?

Neuromuscular disorders : NMD, 2016-04, Vol.26 (4), p.261-263

Mercuri, Eugenio

2016

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

IL-12 receptor. II. Distribution and regulation of receptor expression

Affinity requirements for induction of sequential phases of human B cell activation by membrane IgM-cross-linking ligands

The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2)

Membrane IgM-mediated signaling of human B cells. Effect of increased ligand binding site valency on the affinity and concentration requirements for inducing diverse stages of activation

HMG-CoA Reductase Inhibitors Pravastatin and Simvastatin Inhibit Human B-Lymphocyte Activation

Evidence for an upper affinity threshold for anti-IgM-induced apoptosis in a human B-cell lymphoma

Human B cell activation. Effect of T cell cytokines on the physicochemical binding requirements for achieving cell cycle progression via the membrane IgM signaling pathway

Anti-IgM-mediated B cell signaling: molecular analysis of ligand binding requisites for human B cell clonal expansion and tolerance

Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations

Human B cell activation. Evidence for diverse signals provided by various monoclonal anti-IgM antibodies

Biological function and distribution of human interleukin‐12 receptor β chain

Differential effects of cyclosporin A on diverse B cell activation phenomena triggered by crosslinking of membrane IgM

Cytokine Dependency of Human B Cell Cycle Progression Elicited by Ligands Which Coengage BCR and the CD21/CD19/CD81 Costimulatory Complex

Culture-well solid-phase 3H-RIA for the isotype-specific measurement of antibody from mouse and human antibody-secreting cells

Membrane IgM-Stimulated Human B Lymphocytes Succumb to Activation-Related Apoptosis at a G1→ S Transition: Influence of Ligand Affinity and Valency

A monovalent C mu 4-specific ligand enhances the activation of human B cells by membrane IgM cross-linking ligands

Analysis of the domain specificity of various murine anti-human IgM monoclonal antibodies differing in human B lymphocyte signaling activity

Membrane Ig-mediated triggering of B cell tolerance and B cell clonal expansion: implications for rheumatoid factor production in rheumatoid synovitis

European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10‐year experience

POGLUT1 biallelic mutations cause myopathy with reduced satellite cells, α-dystroglycan hypoglycosylation and a distinctive radiological pattern

The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials

Developing standardized corticosteroid treatment for Duchenne muscular dystrophy

Health related quality of life in young, steroid-naïve boys with Duchenne muscular dystrophy

A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial

Registries versus tertiary care centers: How do we measure standards of care in Duchenne muscular dystrophy?

Aktive Filter

Suchergebnisse filtern